The Food and Drug Administration granted 510(k) clearance for commercial distribution to Bolas Inc.'s (Nasdaq: BIOL) Epic Pro laser system sending the stock price up 21 cents to close at $1.68.
FDA grants clearance to Biolase
January 23, 2017 at 18:13 PM EST
